Abstract
Rationale: The aim of this review was to investigate whether transitioning to SMOFlipid® (soybean/MCT/Olive/Fish) in those on long term home parenteral nutrition (HPN) on a glucose only regime and infrequent 1st generation lipid emulsion will impact liver function parameters among adult Intestinal Failure patients. The development of Intestinal Failure- associated liver disease (INFALD) is multifactorial and displays a broad spectrum ranging from mild cholestasis to cirrhosis and decompensated liver disease. Improved liver function will increase quality of life and life expectancy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
